Prevalence of smoking, quit attempts and access to cessation treatment among adults with mental illness in Brazil: a cross-sectional analysis of a National Health Survey.
delivery of health care
mental disorders
prevalence
smoking cessation
tobacco use
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
26 05 2020
26 05 2020
Historique:
entrez:
29
5
2020
pubmed:
29
5
2020
medline:
15
5
2021
Statut:
epublish
Résumé
Determine the national prevalence of smoking and factors related to smoking among adults with mental illness (PLWMI; people living with mental illness) in Brazil. Cross-sectional study. We used data from the nationally representative general health survey The survey used a complex probabilistic sample to collect data from 60 202 Brazilians 18 years or older. Primary and secondary outcomes: smoking prevalence and access to smoking cessation treatment. We also assessed past tobacco use, quit attempts and quit ratio among people with and without mental illness. Analyses were conducted in R and were weighted to account for the survey design and generate national estimates. In Brazil, the 2013 smoking prevalence among PLWMI was 28.4% and among people with no mental illness was 12.8%. Both groups had high rates of past-year quit attempts (51.6% vs 55.3%) but the lifetime quit ratio among PLWMI was much lower than those with no mental illness (37% vs 54%). Adjusted odds showed PLWMI were more likely to be current smokers (OR (95% CI)=2.60 (2.40 to 2.82), less likely to be former smokers (OR (95% CI)=0.62 (0.55 to 0.70)) and as likely to have tried to quit in the past year (OR (95% CI)=0.90 (0.78 to 1.02)). Very few (3.7%) PLWMI and fewer with no mental illness (2.6%) received cessation treatment. Smoking rates among PLWMI are roughly double the rate in the general population. Compared with Brazilian smokers without mental illness, those with mental illness were significantly less likely to quit even though as many tried to. Few Brazilians appear to be using publicly available cessation services. Expanding utilisation of treatment might be a good place to start for Brazil to further decrease the prevalence of smoking among PLWMI.
Identifiants
pubmed: 32461292
pii: bmjopen-2019-033959
doi: 10.1136/bmjopen-2019-033959
pmc: PMC7259849
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e033959Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Psychiatr Res. 2014 Jan;48(1):102-10
pubmed: 24139811
BMJ. 2014 Feb 13;348:g1151
pubmed: 24524926
Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007253
pubmed: 23450574
MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-59
pubmed: 29346338
Cad Saude Publica. 2005;21 Suppl:54-64
pubmed: 16462997
Nicotine Tob Res. 2007 Jun;9(6):687-97
pubmed: 17558826
Bipolar Disord. 2015 Sep;17(6):575-97
pubmed: 26238269
Behav Med. 2018 Apr-Jun;44(2):160-170
pubmed: 28876188
J Clin Psychopharmacol. 2019 Mar/Apr;39(2):108-116
pubmed: 30811371
BMC Health Serv Res. 2018 Jul 11;18(1):542
pubmed: 29996855
Aust N Z J Psychiatry. 2017 Apr;51(4):366-381
pubmed: 28195010
Issues Ment Health Nurs. 2018 Dec;39(12):1031-1038
pubmed: 30620628
Lancet Psychiatry. 2019 Jul;6(7):563-564
pubmed: 30981756
Int J Soc Psychiatry. 2017 Dec;63(8):669-673
pubmed: 28920521
Psychiatr Serv. 2018 Feb 1;69(2):147-153
pubmed: 28945183
Tob Control. 2018 Nov;27(6):637-642
pubmed: 29123024
Drug Alcohol Depend. 2017 Nov 1;180:204-207
pubmed: 28918239
Prev Med. 2016 Nov;92:110-117
pubmed: 26902875
Eur Psychiatry. 2018 Aug;52:22-28
pubmed: 29609056
Subst Abus. 2017 Jan-Mar;38(1):35-39
pubmed: 27897468
MMWR Morb Mortal Wkly Rep. 2018 May 11;67(18):519-523
pubmed: 29746451
J Health Soc Behav. 1997 Mar;38(1):21-37
pubmed: 9097506
Int Rev Psychiatry. 2014 Aug;26(4):515-23
pubmed: 25137119
BMJ. 2013 May 21;346:f2539
pubmed: 23694688
Annu Rev Public Health. 2017 Mar 20;38:165-185
pubmed: 27992725
J Consult Clin Psychol. 2004 Dec;72(6):1144-56
pubmed: 15612860
BMC Public Health. 2009 Aug 07;9:285
pubmed: 19664203
JAMA. 2014 Jan 8;311(2):172-82
pubmed: 24399556
Lancet Psychiatry. 2019 May;6(5):379-390
pubmed: 30975539
Cien Saude Colet. 2014 Feb;19(2):539-52
pubmed: 24863830
CA Cancer J Clin. 2018 Mar;68(2):106-115
pubmed: 29384589
Lancet. 2017 May 13;389(10082):1885-1906
pubmed: 28390697
Braz J Psychiatry. 2013 Oct-Dec;35(4):338-46
pubmed: 24402207
Prev Chronic Dis. 2006 Apr;3(2):A42
pubmed: 16539783
J Gen Intern Med. 2019 Jun;34(6):986-991
pubmed: 30783880
PLoS One. 2015 Mar 25;10(3):e0120581
pubmed: 25807109
JAMA. 2014 Jan 8;311(2):183-92
pubmed: 24399557
Rev Saude Publica. 2007 Aug;41(4):510-6
pubmed: 17589747
Cad Saude Publica. 2014 Jun;30(6):1195-206
pubmed: 25099043
Schizophr Res. 2005 Jul 15;76(2-3):135-57
pubmed: 15949648